Rebecca K Viscusi

  • 430 Citations
  • 7 h-Index
20122018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Rebecca K Viscusi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Cadaver Medicine & Life Sciences
Random Allocation Medicine & Life Sciences
Medical Students Medicine & Life Sciences
Breast Medicine & Life Sciences
Multiple Hamartoma Syndrome Medicine & Life Sciences
Inflammatory Breast Neoplasms Medicine & Life Sciences
Megalencephaly Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2018

  • 430 Citations
  • 7 h-Index
  • 10 Article
  • 1 Chapter
  • 1 Review article
2 Citations (Scopus)

Learning preferences of surgery residents: A multi-institutional study

Kim, R. H., Viscusi, R. K., Collier, A. N., Hunsinger, M. A., Shabahang, M. M., Fuhrman, G. M. & Korndorffer, J. R., Jan 1 2018, (Accepted/In press) In : Surgery (United States).

Research output: Contribution to journalArticle

Learning
Ear
Equipment and Supplies
Population
Linear Models

Assessment and designation of breast cancer stage

Neumayer, L. A. & Viscusi, R. K., Aug 24 2017, The Breast: Comprehensive Management of Benign and Malignant Diseases. Elsevier Inc., p. 531-552.e6

Research output: Chapter in Book/Report/Conference proceedingChapter

Breast Neoplasms
Neoplasm Staging
Decision Making
Joints
Therapeutics
16 Citations (Scopus)

The role of genetic testing in patients with breast cancer a review

Valencia, O. M., Samuel, S. E., Viscusi, R. K., Riall, T. S., Neumayer, L. A. & Aziz, H., Jun 1 2017, In : JAMA Surgery. 152, 6, p. 589-594 6 p.

Research output: Contribution to journalReview article

Genetic Testing
Breast Neoplasms
Costs and Cost Analysis
Mutation
Germ-Line Mutation
118 Citations (Scopus)

Adaptive randomization of neratinib in early breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 11-22 12 p.

Research output: Contribution to journalArticle

Random Allocation
Breast Neoplasms
Biomarkers
Hormones
Neoadjuvant Therapy
186 Citations (Scopus)

Adaptive randomization of veliparib-carboplatin treatment in breast cancer

the I-SPY 2 Investigators, Jul 7 2016, In : New England Journal of Medicine. 375, 1, p. 23-34 12 p.

Research output: Contribution to journalArticle

Carboplatin
Random Allocation
Breast Neoplasms
Biomarkers
Triple Negative Breast Neoplasms